These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study. Breynaert C; Ferrante M; Fidder H; Van Steen K; Noman M; Ballet V; Vermeire S; Rutgeerts P; Van Assche G Am J Gastroenterol; 2011 Apr; 106(4):778-85. PubMed ID: 21407184 [TBL] [Abstract][Full Text] [Related]
5. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632 [TBL] [Abstract][Full Text] [Related]
6. Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1. Bernateck M; Rolke R; Birklein F; Treede RD; Fink M; Karst M Anesth Analg; 2007 Oct; 105(4):1148-51, table of contents. PubMed ID: 17898403 [TBL] [Abstract][Full Text] [Related]
8. Timing infliximab therapy in pediatric Crohn's disease. Kirschner BS; Huo D Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435 [No Abstract] [Full Text] [Related]
9. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab]. Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078 [TBL] [Abstract][Full Text] [Related]
10. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab. Moss AC; Treister NS; Marsee DK; Cheifetz AS Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307 [No Abstract] [Full Text] [Related]
11. Combination therapy with infliximab and immunomodulators: is the glass half empty? Deshpande AR; Abreu MT Gastroenterology; 2008 Jun; 134(7):2161-3. PubMed ID: 18482585 [No Abstract] [Full Text] [Related]
12. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Fabre C; Dereure O Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487 [No Abstract] [Full Text] [Related]
13. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks. Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832 [TBL] [Abstract][Full Text] [Related]
14. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease. Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639 [No Abstract] [Full Text] [Related]
15. Infusion reactions and their management. Mayer L; Young Y Gastroenterol Clin North Am; 2006 Dec; 35(4):857-66. PubMed ID: 17129817 [TBL] [Abstract][Full Text] [Related]